For 2007, the WHO estimated 511,000 cases of multidrug-resistant (MDR)-TB, representing approximately 5% of all TB cases worldwide. Extensively drug-resistant (XDR-TB) strains have been detected ...

A slew of papers appearing online in Nature Genetics today (September 1) aims to enhance scientists’ understanding of drug-resistant tuberculosis (TB), using whole-genome sequencing to analyze more ...

Tuberculosis remains one of the top infectious disease killers worldwide, a challenge amplified by drug-resistant forms of the disease. Now, in a major step forward, an international clinical trial ...

The primary goals of this resurgent activity are to shorten and simplify the treatment of active TB, provide safer and more efficacious treatments for drug-resistant TB, simplify treatment of TB ...

"Multidrug-resistant TB is a major global public health problem, affecting over 400,000 people each year. It is associated with significantly poorer outcomes than drug-susceptible TB," said ...

The Global Alliance for TB Drug Development and Tibotec have joined forces to develop a potential first-in-class drug for both drug-susceptible and drug-resistant tuberculosis. In June ...

Child MDR-TB is also more common in countries with a high burden of drug-resistant TB among adults, for example, parts of Eastern Europe, Central Asia, and India, Dr. Dubey highlighted.

The drug- which works by targeting Mycobacterium tuberculosis’ defences rather than the bacteria itself - can also take out its increasingly commonly antibiotic resistant strains. The research funded ...

Cases of drug-resistant TB (DR-TB) rose 3% in 2021 over the previous year, the first increase since record-keeping started in 2004, according to the WHO report, which called for countries to move ...

Three all-oral 9-month treatments for drug-resistant tuberculosis were found to be noninferior to standard treatment. Just two in five people with resistant TB receive treatment for the infection.